Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.
Medline has entered into a “definitive agreement” to buy the surgical division, giving the company access to a variety of surgical supplies and equipment used by clinicians and patients.
The move will bring together 24 representatives—12 from each party—who will work to stimulate American AI innovation while mitigating AI-related threats.
Generative AI of the “large language” kind has been an attention hog over the past 10 or 11 months. The buzz has been so loud and constant that it’s all but asking to be dismissed as hype.
